Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD16 for early stages in Hodgkin lymphoma
2007-004474-24Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Mar 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of doxorubicin, bleomycin, vinblastine and dacarbazine in Hodgkin lymphoma (HL), sponsored by University of Cologne. Started Mar 2009; status: completed.
02
Drugs
doxorubicinbleomycinvinblastinedacarbazine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2007-004474-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004474-24.